Back in October 2013, I wrote about Zero Gravity Solutions, a Boca Raton biotech firm bringing to market products researched on the International Space Station. ZGSI was the subject of a Huffington Post article about using biotech research to address crop damage caused by climate change.
ZGSI issued a press release today announcing the establishment of a subsidiary in the United Kingdom.
Zero Gravity Solutions, Inc. (ZGSI or “the Company”) (Pink Sheets: ZGSI) announced today that it has established a wholly owned subsidiary, Zero Gravity Solutions Ltd (ZGSL), to service the Company’s operations and interests in the European Union (EU) and other international markets.
As of 16 December 2013, ZGSI is a 100% owner of ZGSL. ZGSL has established an office at Harwell Oxford's Satellite Applications Catapult facility at the Harwell Campus in Oxfordshire, United Kingdom (UK), a major space, biotech and life science development site in the UK. Harwell Oxford is becoming known as Space Central with the European Space Agency building a 50,000 square foot new building on this site. The campus already has 150 companies located there employing 4,500 people. This is estimated to expand to 20,000 over the next five years. Because of the resistance to the use of Genetically Modified Organism (GMO) in food in Europe, we anticipate the EU to become a primary early adopter initially of our BAM-FX™ product and subsequently of our International Space Station (ISS) based plant stem cell technology. The European agricultural market is a USD300 billion/year enterprise as compared to the USA, which is USD175 billion/year.